- CRS Publications
- News
News
Authors:
Date:
Business Wire: August 31, 2016 – AUSTIN, TX, U.S.A. – Caisson Biotech, LLC, has engaged Pickwick Capital Partners, LLC (member FINRA/SIPC), to assist in the sale of the HEPtune® drug-delivery platform. The proprietary platform centers on the use of a naturally occurring sugar polymer, heparosan,…
Authors:
Date:
PRNewswire: August 29, 2016 – STANS, Switzerland, Aug. 29, 2016 – NLS Pharma Group (NLS) announced today that it has initiated enrollment for its “Double-Blind Placebo-Controlled Phase II Study to Determine the Efficacy, Safety, Tolerability and Pharmacokinetics of a Controlled Release (CR)…
Authors:
Date:
PRNewswire: August 25, 2016 – WAYNE, PA, U.S.A. – Egalet Corporation (Nasdaq: EGLT) (“Egalet”), a fully integrated specialty pharmaceutical company focused on developing, manufacturing, and commercializing innovative treatments for pain and other conditions, today announced that researchers will…
Authors:
Date:
Business Wire: August 25, 2016 – PALM BEACH GARDENS, FL, U.S.A. – Transdermal Delivery Solutions Corporation (TDSC), www.TDSC.us, announced today that transdermal delivery veteran Wallace K. “Wally” Reams has joined its Board of Advisors.
Reams (www.linkedin.com/in/wreams) led the acquisition of…
Authors:
Date:
PRNewswire: August 1, 2016 – MOUNTAIN VIEW, CA, U.S.A. – Based on its recent analysis of the food encapsulation market, Frost & Sullivan recognizes Innovative Food Processors, Inc. (IFP) with the 2016 North America Frost & Sullivan Award for Technology Innovation. IFP’s proprietary PrimeCAP…
Authors:
Date:
Business Wire: June 6, 2016 – TORONTO, Canada – Highland Therapeutics Inc.’s wholly owned subsidiary, Ironshore Pharmaceuticals and Development, Inc. (“Ironshore”), today announced positive clinical data from the second phase 3 pivotal trial of its investigational drug product, HLD-200 (delayed-…
